KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Other Accumulated Expenses (2016 - 2025)

Boston Scientific (BSX) has disclosed Other Accumulated Expenses for 17 consecutive years, with $795.0 million as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses fell 10.37% to $795.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $795.0 million through Dec 2025, down 10.37% year-over-year, with the annual reading at $795.0 million for FY2025, 10.37% down from the prior year.
  • Other Accumulated Expenses hit $795.0 million in Q4 2025 for Boston Scientific, down from $862.0 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $1.0 billion in Q1 2022 to a low of $669.0 million in Q3 2021.
  • Historically, Other Accumulated Expenses has averaged $824.9 million across 5 years, with a median of $804.5 million in 2023.
  • Biggest five-year swings in Other Accumulated Expenses: surged 46.67% in 2022 and later dropped 23.89% in 2023.
  • Year by year, Other Accumulated Expenses stood at $783.0 million in 2021, then fell by 2.81% to $761.0 million in 2022, then rose by 6.96% to $814.0 million in 2023, then grew by 8.97% to $887.0 million in 2024, then fell by 10.37% to $795.0 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for BSX at $795.0 million in Q4 2025, $862.0 million in Q3 2025, and $952.0 million in Q2 2025.